Youth 6 to less than 18 years old with chronic plaque psoriasis for at least 6 months, may qualify to participate in this study. Individuals must have plaque psoriasis inadequately controlled with phototherapy and/or topical therapy, as well as moderate to severe disease severity at the time of study entry.
Participants will receive study medication via injection depending on which part they are enrolled in:
Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.
Participation will last about 74 weeks and include about 12-16 visits to the study centre. Participants may then be offered the opportunity to participate in a long-term extension of the study.
Call the study centre near you or register now.
All information about you will be kept confidential.
If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.
By registering you are consenting to the terms and conditions of our privacy policy.
Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more
© 2014 All Rights Reserved Probity Medical Research Inc.